quinidine has been researched along with amiodarone in 212 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 95 (44.81) | 18.7374 |
| 1990's | 57 (26.89) | 18.2507 |
| 2000's | 36 (16.98) | 29.6817 |
| 2010's | 22 (10.38) | 24.3611 |
| 2020's | 2 (0.94) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Arieff, Z; Bardien-Kruger, S; Brink, P; Chandy, KG; Corfield, V; Wulff, H | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Pajeva, IK; Wiese, M | 1 |
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Budriesi, R; Chiarini, A; Ioan, P; Sparatore, F; Tasso, B; Terranova, E; Ugenti, MP; Vazzana, I | 1 |
| Abraham, S; Barrett, TD; Beatch, GN; Clohs, L; Dong, Y; Fedida, D; Jung, GL; Liu, Y; Lynn, L; Plouvier, B; Sheng, T; Walker, MJ; Wall, RA; Wang, WQ; Zhu, JJ; Zolotoy, A | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Jia, L; Sun, H | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Budriesi, R; Chiarini, A; Ioan, P; Micucci, M; Novelli, F; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M; Vazzana, I | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bruno, C; Budriesi, R; Carbonara, R; Carocci, A; Catalano, A; Colabufo, NA; Conte Camerino, D; De Palma, A; Desaphy, JF; Di Mola, A; Franchini, C; Ghelardini, C; Lentini, G; Perrone, MG | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Adebesin, AM; Falck, JR; Fischer, R; Konkel, A; Lossie, J; Paudyal, MP; Puli, N; Schunck, WH; Vijaykumar, J; Wesser, T; Westphal, C; Zhu, C | 1 |
| Jewitt, DE | 1 |
| Theisen, K | 1 |
| Attuel, P; Coumel, P; Flammang, D; Lavallée, J; Leclercq, JF; Slama, R | 1 |
| Donaldson, RM | 1 |
| Brochier, M; Fauchier, JP | 1 |
| Vaughan-Williams, EM | 1 |
| Attuel, P; Coumel, P; Leclercq, JF; Milosevic, D | 1 |
| Koch-Weser, J | 1 |
| Anderson, JL; Harrison, DC; Meffin, PJ; Winkle, RA | 1 |
| Alegria, E; Aros, F; Loma-Osorio, A; Malpartida, F; Valles, V | 1 |
| Baĭer, T; Brakhmann, I; Khilbel, T; Kiubler, V; Shmitt, K; Valdeker, B | 1 |
| Denisiuk, VI; Kotsuta, GI; Lipnitskiĭ, TN; Osiadlaia, ES; Pilipchuk, VP; Stepaniuk, AV | 1 |
| Calkins, H; Kadish, A; Morady, F; Schork, A; Shyr, Y | 1 |
| Duff, HJ; Gillis, AM; Hii, JT; Mitchell, LB; Solylo, MA; Wyse, DG | 1 |
| Dabrowski, A | 1 |
| Deiwick, M; Konertz, W; Scheld, HH; Weyand, M | 1 |
| Fomina, IG; Iankin, VV | 1 |
| Chouty, F; Coumel, P; Denjoy, I; Leclercq, JF; Slama, R | 1 |
| Hohnloser, S; Just, H; Meinertz, T; Müller, B; Zehender, M | 1 |
| Candinas, R; Follath, F; Meyer, B | 1 |
| Lin, SO; Su, MJ; Tseng, CD; Tseng, YZ; Wang, CH | 1 |
| Ashavaid, TF; Colvin, RA; Katz, AM; Messineo, FC | 1 |
| Brinker, J; Griffith, LS; Guarnieri, T; Tomaselli, G | 1 |
| Calkins, H; el-Atassi, R; Kadish, A; Morady, F; Schmaltz, S; Sousa, J | 1 |
| DiMarco, JP | 1 |
| Alekseevskaia, MA; Maevskaia, IV; Nedostup, AV | 1 |
| Balser, JR; Bennett, PB; Hondeghem, LM; Roden, DM | 1 |
| Boesch, D; Loor, F; Muller, K; Pourtier-Manzanedo, A | 1 |
| Nedostup, AV; Syrkin, AL | 1 |
| Kadish, A; Morady, F; Toivonen, L | 1 |
| Crijns, HJ; Gosselink, AM; Hillege, H; Lie, KI; Van Gelder, IC; Van Gilst, WH | 1 |
| Scheinman, MM | 1 |
| Alvarez, A; Llordes, M; Oliveras, C; Sáenz, L | 1 |
| Mazur, NA; Shestakova, NV | 1 |
| Singh, BN; Takanaka, C | 1 |
| Luke, RA; McAlister, HF; Smith, WM; Whitlock, RM | 2 |
| Kay, GN | 1 |
| Alekseevskaia, MA; Maevskaia, IV; Nedostup, AV; Novikov, ID | 1 |
| Bauernfeind, RA; Welch, WJ | 1 |
| De Ponti, C; Gibelli, G; Negrini, M | 1 |
| Oleĭnikov, VE; Tatarchenko, IP; Zhivotovskaia, GG | 1 |
| Reĭngardene, DI | 1 |
| Roden, DM; Woosley, RL | 1 |
| Yamaguchi, I | 1 |
| Somberg, J | 1 |
| Roden, DM; Siddoway, LA; Woosley, RL | 1 |
| Roy, D | 1 |
| Anderson, JL | 1 |
| Bayés de Luna, A; Guindo, J; Oter, MC | 1 |
| Belhassen, B; Laniado, S; Pines, A | 1 |
| Chittolini, L; Cozzi, E; Ghiringhelli, S; Glisenti, F; Straneo, G; Straneo, U; Tsialtas, D | 1 |
| Echt, DS; Roden, DM; Woosley, RL | 1 |
| Morganroth, J; Nestico, PF | 2 |
| Huang, SK; Marcus, FI | 1 |
| Light, RT; Onrot, J; Robertson, D; Robertson, RM; Tantengco, MV | 1 |
| Bernardeau, C; Fontaine, G; Frank, R; Grosgogeat, Y; Lechat, P; Tonet, JL; Touzet, I | 1 |
| Alburquerque, J; González, R; Martínez, A; Mercadal, E | 1 |
| Agmon, J; Caspi, A; Kusniec, J; Lewin, RF; Sclarovsky, S; Strasberg, B | 1 |
| Gudim, EV; Kotsuta, GI; Lipnitskiĭ, TN; Pilipchuk, VP | 1 |
| Bjellerup, M; Ljunggren, B | 1 |
| Horowitz, LN; Kay, HR; Kutalek, SP; Rae, AP; Spielman, SR | 1 |
| Gonzalez-Sicilia, L; Hernandez, J; Laorden, ML; Perez, D; Villalobos, JP | 1 |
| Bahamonde, L; Cañas, M; Rosselot, E; Rosselot, I | 1 |
| Cook, TS; DiMarco, JP; Nygaard, TW; Sellers, TD | 1 |
| Nguyen, PT; Scheinman, MM; Seger, J | 1 |
| Tao, GS; Wang, XS; Zhao, CY | 1 |
| Buxton, AE; Flores, BT; Josephson, ME; Marchlinski, FE; Miller, JM; Vassallo, JA | 1 |
| Stewart, PA; Wladimiroff, JW | 1 |
| Fossati, C | 1 |
| Popiliev, I | 1 |
| Sanna, G | 1 |
| Buxton, AE; Josephson, ME | 1 |
| Buchanan, D; Crawford, F; Gillette, PC; Zinner, A | 1 |
| Koren, G | 1 |
| Greenspan, AM; Horowitz, LN; Rae, AP; Sokoloff, NM; Spielman, SR; Webb, CR | 1 |
| Brady, PM; Brown, R; Greenspan, AM; Horowitz, LN; Kay, HR; Mintz, GS; Morganroth, J; Spielman, SR | 1 |
| Adinolfi, L; Bonaduce, D; Chiariello, M; Dote, I; Golia, B; Masullo, LA | 1 |
| DiGregorio, GJ; Fruncillo, RJ; Kozin, SH | 1 |
| Opie, LH | 1 |
| Aloisi, B; Brancati, B; Liistro, M; Mazzaglia, G; Negro, R; Russo, L | 1 |
| Peters, RW | 1 |
| DiBianco, R; Fletcher, RD; Gottdiener, JS | 1 |
| Attuel, P; Coumel, P; Georgiopoulos, G; Halkidis, H; Leclercq, JF; Maisonblanche, P | 1 |
| Kappenberger, L; Meyer, UA; Steinbrunn, W; Tartini, R | 1 |
| Burckhardt, D; Follath, F; Hoffmann, A | 1 |
| Hillis, WS; Whiting, B | 1 |
| Prystowsky, EN | 1 |
| Marcus, FI | 1 |
| Somberg, JC | 1 |
| Ceci, V; Di Marcotullio, G; Dini, P; Milazzotto, F; Polizzi, C; Santini, M | 1 |
| Doherty, JU; Josephson, ME; Kienzle, MG; Williams, PD; Zygmont, D | 1 |
| Jahrmärker, H; Theisen, K | 1 |
| Belhassen, B; Laniado, S; Miller, HI; Pelleg, A | 1 |
| Klein, GJ; Yee, R | 1 |
| Assayag, P; Coumel, P; Leclercq, JF | 1 |
| Motté, G | 1 |
| Rosen, MR; Wit, AL | 1 |
| Block, PJ; Winkle, RA | 1 |
| Kates, RE | 1 |
| Manzur, F; Meruane, J; Saavedra, M | 1 |
| Bensaid, J; Blanc, G; Blanc, P; Chabanier, A; Doumeix, JJ; Roussane, A; Virot, P | 1 |
| Chenzbraun, A; Cohen, AM; Keren, A; Loebel, H; Stern, S; Tzivoni, D; Zahavi, I | 1 |
| Graham, EL; Greene, HL; Saal, AK; Sears, GK; Werner, JA | 1 |
| Burckhardt, D; Follath, F; Hoffmann, A; Schütz, E; White, R | 1 |
| Golitsyn, SP; Grosu, AA; Smetnev, AS; Sokolov, SF | 1 |
| Achilli, A; Serra, N | 1 |
| Coltorti, F; Condorelli, M; Critelli, G; Grassi, G; Monda, V; Perticone, F | 1 |
| D'Arcy, PF | 1 |
| Flinn, CJ; Gelband, H; Pickoff, AS; Singh, S; Wolff, GS | 1 |
| Zeng, GY | 1 |
| Lukoshevichiute, AI; Reĭngardene, DI | 1 |
| Larovere, MT; Morabito, A; Rumolo, R; Tronci, M; Vitolo, E | 1 |
| Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D | 1 |
| Coelho, A; Rosen, KM; Strasberg, B; Welch, WJ | 1 |
| Allaria, B; De Gasperi, A; Romanò, M; Zucco, F | 1 |
| Kappenberger, L; Steinbrunn, W; Tartini, R | 1 |
| Coltorti, F; Condorelli, M; Critelli, G; Gallagher, JJ; Monda, V; Perticone, F | 1 |
| Larovere, MT; Rumolo, R; Tronci, M; Vitolo, E | 1 |
| Benhorin, J; Gavish, D; Gottlieb, S; Keren, A; Levi, J; Stern, S; Tzivoni, D | 1 |
| Achilli, A; Capezzuto, A; De Luca, F; Giacci, M; Guerra, R; Serra, N | 1 |
| Campbell, RW | 1 |
| Chiavarelli, V; Milazzotto, F; Vajola, SF | 1 |
| Bertoni, PD; Di Michele, R; Tosetto, C | 1 |
| Bär, FW; Brugada, P; Dassen, WR; Farré, J; Vanagt, EJ; Wellens, HJ | 1 |
| Bebee, R; Freitag, D; Sunderland, B | 1 |
| Amato, RV; Bellotti, G; César, LA; D'Avila, AL; Ferreira, JF; Pamplona, D; Pfeferman, E; Scanavacca, M; Serrano, CV; Sosa, EA | 1 |
| Gornbein, JA; Middlekauff, HR; Stevenson, WG | 1 |
| Just, H; Meinertz, T; Zehender, M | 1 |
| Patterson, FK; Wigler, PW | 1 |
| Faber, TS; Hohnloser, S; Just, H; Van de Loo, A; Zehender, M | 1 |
| Cowan, JC | 1 |
| Lüderitz, B; Manz, M | 1 |
| Fromm, BS; Lehmann, MH; Makkar, RR; Meissner, MD; Steinman, RT | 1 |
| Almendral, JM; Arenal, A; Delcán, JL; Lorca, MT; Pastor, A | 1 |
| Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R | 1 |
| Birkmeyer, JD; Disch, DL; Greenberg, ML; Holzberger, PT; Malenka, DJ | 1 |
| Gurfinkel, E; Mautner, B; Pazos, AA | 1 |
| Ansari-Leesar, M; Cohen, A; Faitel, K; Frumin, H; Kerin, NZ; Narala, C | 1 |
| Faitel, K; Kerin, NZ; Naini, M | 1 |
| Darius, H; Genth, S; Himmrich, E; Meyer, J; Treese, N; Zotz, R | 1 |
| Roden, DM | 1 |
| DiMarco, JP; Jung, F | 1 |
| Disch, DL; Greenberg, ML; Malenka, DJ | 1 |
| Alsagheer, S; Beurrier, D; Brembilla-Perrot, B; Grentzinger, A; Jacquemin, L; Retournay, G | 1 |
| Chow, MS; Kluger, J; Tran, HT | 1 |
| Matsumori, A; Nishio, R; Nose, Y; Ono, K; Sasayama, S | 1 |
| Behrens, S; Franz, MR; Hohnloser, SH; Woosley, RL; Zabel, M | 1 |
| Epstein, LM; Huang, DT; Josephson, ME; Monahan, KM; Papageorgiou, P; Zimetbaum, P | 1 |
| Humphries, JO | 1 |
| D'Andrea, A; Ducceschi, V; Iacono, A; Liccardo, B; Santangelo, L; Sarubbi, B | 1 |
| Lewalter, T; Lüderitz, B | 1 |
| Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL | 1 |
| Gutierrez, J; Raviña, T | 1 |
| Bigler, L; Follath, F; Ha, HR; Kozlik, P; Stieger, B | 1 |
| Farkas, A; Leprán, I; Papp, JG | 1 |
| Kakumoto, M; Kita, T; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Chu, J; Hoffman, RS; Howland, MA; Nelson, LS; Su, M | 1 |
| Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL | 1 |
| Kao, W; Kowey, PR; Winkel, E; Yan, GX | 1 |
| Bulanova, NA; Kositsyna, IV; Morozova, MN; Tereshchenko, SN; Uteshev, IuA | 1 |
| Borbély, M; Dani, G; Erdej, F; Hajdara, I; Katona, A; Márk, L; Nagy, E; Sziklai, G | 1 |
| Dorian, P; Humphries, KH; Kerr, CR; Steinbuch, M | 1 |
| Cvetanovic, I; Ke, X; Lin, C; Ranade, V; Somberg, J | 1 |
| Belhassen, B | 1 |
| Scharf, C | 1 |
| Hamlin, RL; Keene, BW; Kijtawornrat, A; Nishijima, Y; Roche, BM | 1 |
| Dolgosheĭ, TS; Kokhkovski, AB; Liskovich, TG; Madeshkina, GA; Mironchik, EV; Tyshchenko, AD | 1 |
| Bakula, M; Frank, B; Gavranovic, Z; Milicevic, G; Pazur, V | 1 |
| Matsumoto, A; Miki, T; Nakaya, H; Nishida, A; Seino, S; Takizawa, T | 1 |
| Hu, ZY; Zhao, Y | 1 |
| Amit, G; Asher, E; Belhassen, B; Chorin, E; Halkin, A; Havakuk, O; Hochstadt, A; Laish-Farkash, A; Lee, JK; Rosso, R; Tovia-Brodie, O; Viskin, D; Viskin, S | 1 |
| Wang, H; Wang, Q; Zhang, Q; Zhong, Y | 1 |
| Alrayes, H; El-Khatib, L; Elbanna, A; Sallam, O | 1 |
| Bove, T; Cilenti, F; Copetti, R; Cristiani, L; Guglielmo, N; Orso, D; Santangelo, S | 1 |
40 review(s) available for quinidine and amiodarone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Limitations of present drug therapy of cardiac arrhythmias--a review.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Lidocaine; Procainamide; Quinidine; Verapamil | 1977 |
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
[Mechanisms of interactions of anti-arrhythmia agents during their combined use].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Potassium; Procainamide; Propranolol; Quinidine; Verapamil | 1991 |
[The interaction of antiarrhythmic drugs with other drugs].
Topics: Adrenergic beta-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Digoxin; Drug Interactions; Humans; Lidocaine; Mexiletine; Phenytoin; Procainamide; Quinidine | 1985 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium Channel Blockers; Cell Membrane; Disopyramide; Electrophysiology; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1986 |
Rationale of combination antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Digitalis Glycosides; Drug Therapy, Combination; Humans; Mexiletine; Myocardial Infarction; Quinidine; Tachycardia; Verapamil | 1985 |
Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Digitalis; Disopyramide; Drug Interactions; Encainide; Flecainide; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Lidocaine; Liver; Piperidines; Plants, Medicinal; Plants, Toxic; Potassium; Procainamide; Quinidine; Regional Blood Flow; Tocainide | 1986 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
Systemic drug photosensitivity.
Topics: Amiodarone; Animals; Anti-Inflammatory Agents; Benzodiazepines; Benzofurans; Griseofulvin; Humans; Nalidixic Acid; Phenothiazines; Photosensitivity Disorders; Quinidine; Quinine; Sulfonamides; Tetracyclines | 1986 |
[Pharmacologic interaction of amiodarone with other drugs].
Topics: Amiodarone; Benzofurans; Digoxin; Drug Interactions; Humans; Kinetics; Quinidine; Tachycardia | 1985 |
[Amiodarone: pharmacology, clinical use and side effects].
Topics: Amiodarone; Arrhythmias, Cardiac; Autonomic Nervous System; Benzofurans; Blood Coagulation; Digitalis Glycosides; Drug Synergism; Electrocardiography; Heart; Heart Conduction System; Hemodynamics; Humans; Kinetics; Quinidine; Sick Sinus Syndrome; Thyroid Diseases; Thyroid Gland | 1985 |
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Dogs; Encainide; Hemodynamics; Humans; Myocardial Contraction; Quinidine; Verapamil | 1982 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atrial Fibrillation; Benzofurans; Digitalis Glycosides; Disopyramide; Encainide; Female; Humans; Lidocaine; Male; Middle Aged; Procainamide; Quinidine; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1983 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bethanidine; Calcium Channel Blockers; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Encainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Phenytoin; Piperidines; Procainamide; Quinidine; Tachycardia; Tocainide | 1984 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardiac Complexes, Premature; Digoxin; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1980 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Hemodynamic effects of antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide | 1983 |
Metabolites of cardiac antiarrhythmic drugs: their clinical role.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Disopyramide; Encainide; Humans; Lidocaine; Piperidines; Procainamide; Quinidine | 1984 |
[Value of drug tests in Wolff-Parkinson-White syndrome].
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; Diagnosis, Differential; Electrocardiography; Humans; Lidocaine; Myocardial Infarction; Procainamide; Quinidine; Verapamil; Wolff-Parkinson-White Syndrome | 1981 |
Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Confounding Factors, Epidemiologic; Decision Support Techniques; Electric Countershock; Female; Humans; Male; Middle Aged; Quinidine; Risk; Thromboembolism; Treatment Outcome; Warfarin | 1995 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramide; Female; Humans; Male; Middle Aged; Prenylamine; Procainamide; Quinidine; Risk Factors; Sex; Sotalol; Syncope; Tachycardia, Ventricular; Torsades de Pointes | 1993 |
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; Electric Countershock; Flecainide; Humans; Propafenone; Quinidine; Recurrence; Sotalol | 1993 |
Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone.
Topics: Aged; Amiodarone; Atrial Fibrillation; Chronic Disease; Decision Support Techniques; Humans; Markov Chains; Quality of Life; Quinidine; Risk Factors; Warfarin | 1994 |
Is there a need for new antiarrhythmic drugs?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Propafenone; Quinidine; Sotalol; Torsades de Pointes | 1996 |
Antiarrhythmic drug therapy in the treatment of atrial fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Electrophysiology; Flecainide; Humans; Ion Channels; Quinidine; Sotalol; Sulfonamides | 1996 |
Therapeutic strategies for atrial fibrillation. The value of decision analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Decision Support Techniques; Electric Countershock; Humans; Markov Chains; Quinidine; Randomized Controlled Trials as Topic; Warfarin | 1996 |
Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Coronary Artery Bypass; Death, Sudden, Cardiac; Electric Countershock; Humans; Meta-Analysis as Topic; Monitoring, Physiologic; Postoperative Care; Postoperative Complications; Procainamide; Quinidine; Recurrence; Risk Factors; Time Factors | 1998 |
Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Digoxin; Electric Countershock; Flecainide; Humans; Procainamide; Quinidine; Verapamil | 1998 |
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil | 2000 |
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States | 2003 |
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left | 2003 |
[Chronic heart failure and atrial fibrilation: aspects of management].
Topics: Acute Disease; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Electric Countershock; Heart Failure; Humans; Quinidine; Randomized Controlled Trials as Topic; Sotalol; Sympatholytics; Time Factors; Vasodilator Agents | 2003 |
[Atrial flutter and fibrillation].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2005 |
Bayesian Network Meta-analysis of Randomized Controlled Trials on the Efficacy of Antiarrhythmics in the Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Flecainide; Humans; Network Meta-Analysis; Quinidine; Randomized Controlled Trials as Topic; Ranolazine; Systematic Reviews as Topic; Verapamil | 2023 |
14 trial(s) available for quinidine and amiodarone
| Article | Year |
|---|---|
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
[Maintaining sinus rhythm with quinidine and amiodarone after electric cardioversion].
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Drug Evaluation; Electric Countershock; Female; Heart Conduction System; Humans; Male; Quinidine | 1978 |
[Prospective course of therapy arresting attacks of atrial fibrillation in patients with preexcitation syndromes].
Topics: Adult; Aged; Aged, 80 and over; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged; Moricizine; Pre-Excitation Syndromes; Procainamide; Propranolol; Quinidine; Time Factors; Verapamil | 1992 |
Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up.
Topics: Amiodarone; Atrial Fibrillation; Chronic Disease; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Prospective Studies; Quinidine; Treatment Outcome; Verapamil | 1992 |
Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Female; Humans; Injections, Intravenous; Male; Prognosis; Quinidine; Randomized Controlled Trials as Topic; Recurrence | 1990 |
[Comparison of amiodarone and quinidine in the conversion to sinusal rhythm of atrial fibrillation of recent onset].
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Drug Evaluation; Echocardiography; Female; Humans; Male; Middle Aged; Quinidine; Random Allocation; Time Factors | 1990 |
Interatrial conduction block with retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias: influence of preventive antiarrhythmic treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Follow-Up Studies; Heart Atria; Heart Block; Humans; Male; Middle Aged; Quinidine; Tachycardia, Supraventricular; Verapamil | 1989 |
Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Procainamide; Quinidine; Tachycardia; Time Factors; Ventricular Fibrillation | 1987 |
Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Death, Sudden; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Ventricles; Humans; Injections, Intravenous; Male; Middle Aged; Procainamide; Quinidine; Risk; Syncope; Tachycardia; Time Factors | 1986 |
[Impressions and certainties concerning the harmful effects of anti-arrhythmic drugs].
Topics: Acetylation; Amiodarone; Anilides; Anti-Arrhythmia Agents; Clinical Trials as Topic; Encainide; Humans; Kinetics; Molecular Biology; Placebos; Procainamide; Quinidine | 1985 |
Amiodarone versus quinidine in the prophylaxis of atrial fibrillation.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Clinical Trials as Topic; Coronary Disease; Female; Gastrointestinal Diseases; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Quinidine; Random Allocation; Risk; Triiodothyronine | 1981 |
[Acute atrial fibrillation in the emergency room. Which is the best drug for a rapid sinus rhythm conversion?].
Topics: Acute Disease; Adult; Aged; Amiodarone; Atrial Fibrillation; Emergencies; Female; Humans; Male; Middle Aged; Procainamide; Quinidine; Sinoatrial Node; Time Factors | 1994 |
[Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].
Topics: Aged; Amiodarone; Atrial Fibrillation; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Humans; Long-Term Care; Male; Middle Aged; Prospective Studies; Quinidine; Treatment Outcome; Verapamil | 1994 |
The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Digoxin; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Quinidine; Treatment Outcome | 1996 |
159 other study(ies) available for quinidine and amiodarone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI).
Topics: Amino Acid Sequence; Animals; Base Sequence; Cloning, Molecular; COS Cells; DNA; Heart Block; Heart Diseases; Humans; Mice; Molecular Sequence Data; Potassium Channels; Potassium Channels, Voltage-Gated; Shaker Superfamily of Potassium Channels; Trinucleotide Repeats | 2002 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
Topics: Adenosine Triphosphatases; Algorithms; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Binding, Competitive; Caco-2 Cells; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rhodamine 123; Stereoisomerism; Verapamil; Vinblastine | 2002 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Novel quinolizidinyl derivatives as antiarrhythmic agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Electrocardiography; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isometric Contraction; Lidocaine; Muscle, Smooth, Vascular; Myocardial Contraction; Procainamide; Quinidine; Quinolizines; Stimulation, Chemical; Structure-Activity Relationship; Vasodilation | 2007 |
Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillation.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Biological Availability; Cell Line; Crystallography, X-Ray; Cyclohexanes; Dogs; Electric Stimulation; Ethers; Female; Humans; Male; Mice; Molecular Structure; Myocardial Ischemia; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium Channels; Stereoisomerism; Structure-Activity Relationship | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Electric Stimulation; Guinea Pigs; Heart; Heart Rate; Ileum; In Vitro Techniques; Muscle, Smooth; Myocardial Contraction; Platelet Aggregation Inhibitors; Quinolizidines; Receptor, Muscarinic M2; Stereoisomerism; Structure-Activity Relationship; Vasodilator Agents | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Ataxia; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Caco-2 Cells; Guinea Pigs; Heart; Heart Rate; HEK293 Cells; Humans; Ion Channel Gating; Mexiletine; Mice; NAV1.5 Voltage-Gated Sodium Channel; Permeability; Sodium Channels; Stereoisomerism; Vasodilator Agents | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of Robust 17(
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arachidonic Acids; Dose-Response Relationship, Drug; Drug Stability; Epoxide Hydrolases; Esterification; Hepatocytes; Humans; Male; Mice; Microsomes, Liver; Myocardial Infarction; Myocytes, Cardiac; Rats, Sprague-Dawley; Rats, Wistar | 2019 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1978 |
[The atrial arrhythmia syndrome of vagal origin].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Atrial Fibrillation; Atrial Flutter; Drug Resistance; Female; Humans; Male; Middle Aged; Pacemaker, Artificial; Quinidine; Vagus Nerve | 1978 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Digoxin; Disopyramide; Electric Countershock; Humans; Phenytoin; Procainamide; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1979 |
["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Bretylium Compounds; Cardiac Complexes, Premature; Humans; Phenytoin; Prenylamine; Quinidine; Tachycardia; Ventricular Fibrillation; Verapamil | 1978 |
[Research on a rational basis for the origin and treatment of arrhythmia].
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Heart; Humans; Hyperthyroidism; Potassium; Propranolol; Quinidine; Rabbits; Refractory Period, Electrophysiological; Sodium; Verapamil | 1977 |
[Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Computers; Electrocardiography; Heart Ventricles; Humans; Placebos; Propranolol; Quinidine | 1979 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1978 |
[Anti-arrhythmia agents in heart failure].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Flecainide; Humans; Mexiletine; Middle Aged; Propafenone; Quinidine | 1992 |
[Clinical effectiveness of cordarone in combination with other anti-arrhythmia agents in refractory atrial fibrillation and adverse effects of the drugs].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Drug Therapy, Combination; Humans; Middle Aged; Moricizine; Quinidine; Verapamil | 1992 |
Effects of quinidine and amiodarone on blood pressure during rapid ventricular pacing in coronary artery disease.
Topics: Aged; Amiodarone; Analysis of Variance; Blood Pressure; Cardiac Pacing, Artificial; Coronary Disease; Female; Humans; Male; Middle Aged; Quinidine; Regression Analysis | 1992 |
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Quinidine; Torsades de Pointes | 1992 |
[Should the patients with atrial fibrillation receive long-term anti-arrhythmia treatment after successful cardioversion?].
Topics: Amiodarone; Atrial Fibrillation; Combined Modality Therapy; Contraindications; Electric Countershock; Humans; Long-Term Care; Quinidine; Recurrence; Time Factors | 1992 |
Is pretransplant antiarrhythmic drug therapy a risk factor?
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Cause of Death; Child; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Mexiletine; Middle Aged; Postoperative Complications; Premedication; Propafenone; Quinidine; Sotalol; Survival Rate; Transplantation, Heterotopic | 1992 |
Flecainide in quinidine-resistant atrial fibrillation.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Quinidine; Time Factors | 1992 |
[Drug therapy in supraventricular arrhythmia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Digoxin; Flecainide; Humans; Quinidine; Tachycardia, Supraventricular | 1992 |
Comparison of the electrophysiological effect of amiodarone, lidocaine and quinidine on rat ventricular cells.
Topics: Action Potentials; Amiodarone; Animals; Calcium; Cnidarian Venoms; Ion Channel Gating; Ion Channels; Lidocaine; Potassium; Quinidine; Rats; Sodium; Ventricular Function, Left | 1990 |
Amiodarone, verapamil, and quinidine do not affect equilibrium binding of digoxin.
Topics: Amiodarone; Animals; Binding, Competitive; Digoxin; Dogs; Myocardium; Quinidine; Receptors, Drug; Sarcolemma; Sodium-Potassium-Exchanging ATPase; Verapamil | 1990 |
The interaction of antiarrhythmic drugs and the energy for cardioversion of chronic atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cerebrovascular Disorders; Chronic Disease; Electric Countershock; Electrocardiography; Energy Transfer; Female; Flecainide; Humans; Male; Middle Aged; Quinidine; Stroke Volume; Time Factors | 1991 |
Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
Topics: Amiodarone; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Epinephrine; Female; Heart Conduction System; Humans; Male; Middle Aged; Quinidine; Tachycardia | 1992 |
Epinephrine infusions during antiarrhythmic drug evaluations: toward a better understanding of drug activity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Epinephrine; Humans; Quinidine; Tachycardia | 1992 |
[A method of choosing maintenance anti-arrhythmia therapy after sinus rhythm restoration in patients with a permanent form of atrial fibrillation].
Topics: Amiodarone; Atrial Fibrillation; Coronary Disease; Electric Countershock; Heart Rate; Humans; Methods; Prognosis; Quinidine; Rheumatic Heart Disease | 1991 |
Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone.
Topics: Action Potentials; Amiodarone; Animals; Electrophysiology; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Membrane Potentials; Models, Cardiovascular; Potassium; Potassium Channels; Quinidine; Time Factors; Ventricular Function | 1991 |
Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative.
Topics: Amiodarone; Animals; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Flow Cytometry; Leukemia, Experimental; Leukemia, Myeloid; Microscopy, Fluorescence; Quinacrine; Quinidine; Tumor Cells, Cultured; Verapamil | 1991 |
[Atrial fibrillation. Restoration of the sinus rhythm in patients with a persistent form of atrial fibrillation].
Topics: Adult; Age Factors; Aged; Amiodarone; Atrial Fibrillation; Contraindications; Drug Evaluation; Electric Countershock; Humans; Middle Aged; Quinidine; Sinoatrial Node; Time Factors | 1991 |
A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Encainide; Heart Conduction System; Humans; Mexiletine; Prospective Studies; Quinidine; Tachycardia | 1991 |
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.
Topics: Actuarial Analysis; Aged; Amiodarone; Analysis of Variance; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Drug Administration Schedule; Electric Countershock; Female; Flecainide; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Quinidine; Recurrence; Sotalol | 1991 |
Invasive electrophysiologic studies as predictor of sudden death and for treatment of patients with aborted sudden death.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Child; Death, Sudden; Electric Countershock; Electrophysiology; Female; Follow-Up Studies; Heart; Heart Arrest; Humans; Male; Middle Aged; Procainamide; Quinidine; Tachycardia | 1990 |
[Electrocardiographic changes caused by ionic disorders and drugs].
Topics: Adrenergic beta-Antagonists; Amiodarone; Digitalis; Education, Medical, Continuing; Electrocardiography; Humans; Hypercalcemia; Hyperkalemia; Hypocalcemia; Hypokalemia; Plants, Medicinal; Plants, Toxic; Quinidine | 1990 |
Barium-induced nondriven action potentials as a model of triggered potentials from early afterdepolarizations: significance of slow channel activity and differing effects of quinidine and amiodarone.
Topics: Action Potentials; Amiodarone; Animals; Barium; Calcium Channels; Dogs; Female; Heart Conduction System; Isoproterenol; Male; Membrane Potentials; Purkinje Fibers; Quinidine; Tachycardia; Verapamil | 1990 |
Reply to: Amiodarone and quinidine for postoperative atrial arrhythmias (J Thorac Cardiovasc Surg 1990;99:942)
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Humans; Quinidine | 1990 |
Invited letter concerning: amiodarone and quinidine for postoperative atrial arrhythmias.
Topics: Amiodarone; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Humans; Quinidine | 1990 |
[A comparison of the efficacy of quinidine and kordaron as agents to stabilize the recovered sinus rhythm in patients with the permanent form of atrial fibrillation].
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Drug Evaluation; Electric Countershock; Heart Rate; Humans; Middle Aged; Quinidine | 1990 |
New hope in atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Quinidine; Sotalol | 1990 |
[Anti-arrhythmic action of combinations of trimecaine with quinidine, novocainamide and cordaron (clinico-experimental study)].
Topics: Acetanilides; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Dogs; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Procainamide; Quinidine; Trimecaine | 1985 |
[Ventricular fibrillation caused by the combined administration of amiodarone and quinidine].
Topics: Adolescent; Amiodarone; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; Female; Humans; Quinidine; Ventricular Fibrillation | 1989 |
QT prolongation and arrhythmia suppression.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Deafness; Death, Sudden; Electrocardiography; Heart Atria; Heart Ventricles; Humans; Quinidine; Sotalol; Systole; Tachycardia | 1985 |
Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Drug Therapy, Combination; Electrophysiology; Fluocortolone; Humans; Male; Mexiletine; Quinidine; Sarcoidosis; Tachycardia | 1989 |
[Pharmacological cardioversion of paroxysmal atrial fibrillation: 3 methods compared].
Topics: Aged; Amiodarone; Atrial Fibrillation; Deslanoside; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Methods; Middle Aged; Quinidine; Verapamil | 1987 |
Orthostatic hypotension: clinical spectrum and approach to treatment.
Topics: Adult; Aged; Amiodarone; Disopyramide; Female; Flecainide; Humans; Hypotension, Orthostatic; Lidocaine; Male; Middle Aged; Piperidines; Procainamide; Quinidine; Sympathomimetics; Tocainide | 1986 |
Comparison between the efficacy of amiodarone and quinidine in the treatment of atrial cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Female; Heart; Humans; Male; Middle Aged; Quinidine | 1986 |
[Torsade de pointes: clinical experience of 9 patients].
Topics: Adult; Aged; Amiodarone; Coronary Disease; Electrocardiography; Female; Humans; Hypokalemia; Isoproterenol; Male; Middle Aged; Quinidine; Retrospective Studies; Tachycardia | 1988 |
Ventricular fibrillation in a patient with 'silent' mitral valve prolapse.
Topics: Adult; Amiodarone; Death, Sudden; Drug Therapy, Combination; Electrophysiology; Follow-Up Studies; Heart Arrest; Humans; Male; Mitral Valve Prolapse; Propranolol; Quinidine; Ventricular Fibrillation | 1988 |
[Use of kordaron and Kinilentin in the permanent form of atrial fibrillation].
Topics: Adult; Amiodarone; Atrial Fibrillation; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Quinidine; Time Factors | 1987 |
Compared efficacy of quinidine, amiodarone and diltiazem on both nomotopic and ectopic automaticity in the rat heart.
Topics: Amiodarone; Animals; Atrial Function; Diltiazem; Female; Heart Atria; Heart Rate; Heart Ventricles; In Vitro Techniques; Male; Quinidine; Rats; Rats, Inbred Strains; Ventricular Function | 1987 |
[Electric cardioversion in the postoperative period after mitral valve surgery].
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Electric Countershock; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Postoperative Period; Quinidine; Recurrence | 1986 |
Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Procainamide; Prospective Studies; Quinidine; Tachycardia; Ventricular Fibrillation | 1986 |
Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval.
Topics: Adolescent; Adult; Aged; Amiodarone; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Procainamide; Quinidine; Tachycardia | 1986 |
[Combined amiodarone and quinidine treatment in refractory tachyarrhythmias; clinical observation and experimental electrophysiologic study].
Topics: Action Potentials; Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Drug Therapy, Combination; Electrophysiology; Female; Guinea Pigs; Humans; In Vitro Techniques; Male; Middle Aged; Quinidine; Refractory Period, Electrophysiological | 1986 |
Treatment of fetal cardiac arrhythmias.
Topics: Amiodarone; Arrhythmia, Sinus; Arrhythmias, Cardiac; Chromosome Aberrations; Chromosome Disorders; Diagnosis, Differential; Digoxin; Drug Therapy, Combination; Echocardiography; Edema, Cardiac; Female; Fetal Diseases; Fetal Growth Retardation; Fetal Heart; Gestational Age; Heart Rate; Humans; Karyotyping; Lung; Maternal-Fetal Exchange; Pregnancy; Procainamide; Prognosis; Propranolol; Quinidine; Ultrasonography; Vena Cava, Superior; Verapamil | 1985 |
Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stimulation; Electrophysiology; Heart Arrest; Humans; Procainamide; Prognosis; Quinidine; Tachycardia | 1986 |
Ventricular tachydysrhythmias in near-miss sudden infant death syndrome.
Topics: Amiodarone; Heart Ventricles; Humans; Infant, Newborn; Infusions, Parenteral; Male; Procainamide; Propranolol; Quinidine; Recurrence; Sudden Infant Death; Tachycardia | 1986 |
Interaction between digoxin and commonly coadministered drugs in children.
Topics: Amiodarone; Child, Preschool; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Nifedipine; Quinidine; Spironolactone; Verapamil | 1985 |
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electric Stimulation; Electrophysiology; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Procainamide; Quinidine; Time Factors | 1985 |
Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy.
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Drug Resistance; Female; Humans; Male; Middle Aged; Quinidine | 1985 |
[Ventricular tachycardia].
Topics: Amiodarone; Aprindine; Digitalis Glycosides; Electrocardiography; Heart Aneurysm; Heart Ventricles; Humans; Mexiletine; Pacemaker, Artificial; Propranolol; Quinidine; Risk; Tachycardia; Tachycardia, Paroxysmal | 1985 |
Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
Topics: Amiodarone; Animals; Benzofurans; Half-Life; Kinetics; Lidocaine; Liver; Male; Phenytoin; Quinidine; Rats; Rats, Inbred Strains | 1985 |
Drugs and the heart. IV. Antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Heart Conduction System; Hemodynamics; Humans; Lidocaine; Mexiletine; Procainamide; Quinidine; Verapamil | 1980 |
[Long-term use of amiodarone in the treatment of ventricular pre-excitation with tachyarrhythmia attacks].
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Benzofurans; Drug Therapy, Combination; Humans; Quinidine; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1981 |
[Treatment of supraventricular tachycardia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Electrocardiography; Humans; Quinidine; Tachycardia; Verapamil | 1981 |
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Lidocaine; Propafenone; Propiophenones; Quinidine; Verapamil | 1981 |
Dangerous interaction between amiodarone and quinidine.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Humans; Male; Middle Aged; Quinidine; Tachycardia | 1982 |
Safe treatment of resistant ventricular arrhythmias with a combination of amiodarone and quinidine or mexiletine.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Quinidine | 1983 |
Antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Disopyramide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide; Verapamil | 1983 |
Drug interactions with amiodarone.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Benzofurans; Blood Coagulation Disorders; Calcium; Digoxin; Drug Interactions; Drug Synergism; Heart Arrest; Humans; Kinetics; Quinidine; Tachycardia; Warfarin | 1983 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
[Combinations of some anti-arrhythmia drugs].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Humans; Mexiletine; Propafenone; Propiophenones; Quinidine | 1984 |
Serial electrophysiological studies in a young patient with recurrent ventricular fibrillation.
Topics: Adult; Amiodarone; Electrocardiography; Humans; Male; Quinidine; Recurrence; Ventricular Fibrillation | 1981 |
Wide QRS tachycardia: multiple mechanisms in a patient after myocardial infarction.
Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Heart Conduction System; Humans; Male; Myocardial Infarction; Quinidine; Tachycardia | 1984 |
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Autonomic Nervous System; Cardiac Complexes, Premature; Child; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Propiophenones; Quinidine; Tachycardia; Wolff-Parkinson-White Syndrome | 1984 |
[Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catecholamines; Electrolytes; Heart Conduction System; Humans; Ion Channels; Lidocaine; Prognosis; Quinidine; Verapamil | 1981 |
[Torsade de pointes or atypical ventricular tachycardia in a patient with Chagas' cardiomyopathy].
Topics: Aged; Amiodarone; Chagas Cardiomyopathy; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Quinidine; Tachycardia | 1984 |
[Long-term fate of 103 patients with auricular fibrillation lasting for over 15 days treated with cardioversion and preventive therapy].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Quinidine; Recurrence | 1984 |
Magnesium therapy for torsades de pointes.
Topics: Aged; Amiodarone; Electrocardiography; Female; Humans; Imipramine; Magnesium Sulfate; Male; Middle Aged; Procainamide; Quinidine; Tachycardia; Thioridazine | 1984 |
Effect of amiodarone on serum quinidine and procainamide levels.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Female; Humans; Male; Middle Aged; Procainamide; Prospective Studies; Quinidine | 1984 |
Suppression of high-grade ventricular ectopic activity by antiarrhythmic drug treatment as a marker for survival in patients with chronic coronary artery disease.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Female; Humans; Male; Mexiletine; Middle Aged; Phenytoin; Prognosis; Quinidine; Retrospective Studies | 1984 |
[Method of evaluating antiarrhythmic therapy in patients with paroxysms of supraventricular tachycardia].
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Evaluation; Electric Stimulation; Female; Humans; Male; Middle Aged; Procainamide; Propranolol; Quinidine; Tachycardia, Paroxysmal; Verapamil | 1984 |
Amiodarone increases plasma digoxin concentrations.
Topics: Amiodarone; Benzofurans; Digoxin; Drug Interactions; Humans; Quinidine | 1981 |
Transesophageal pacing for prognostic evaluation of preexcitation syndrome and assessment of protective therapy.
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Cardiac Pacing, Artificial; Death, Sudden; Esophagus; Female; Humans; Male; Prognosis; Quinidine; Wolff-Parkinson-White Syndrome | 1983 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
Use of amiodarone in the therapy of primary ventricular arrhythmias in children.
Topics: Adolescent; Age Factors; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Corneal Diseases; Drug Therapy, Combination; Female; Heart Ventricles; Humans; Male; Prognosis; Propranolol; Quinidine; Retrospective Studies; Tachycardia | 1983 |
[Clinical pharmacology of anti-arrhythmia agents].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Humans; Lidocaine; Quinidine; Verapamil | 1983 |
Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Disopyramide; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Ventricles; Humans; Prajmaline; Pyridines; Quinidine; Tachycardia | 1982 |
Sustained macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Disopyramide; Electrocardiography; Heart Conduction System; Humans; Male; Procainamide; Quinidine; Recurrence; Tachycardia | 1982 |
[Treatment of atrial fibrillation of recent onset by a combination of quinidine and amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinidine; Time Factors | 1982 |
[Harmful interactions of amiodarone and class I anti-arrhythmia agents].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Quinidine; Tachycardia | 1982 |
[Closed chest interruption of A-V conduction in the treatment of refractory supraventricular tachyarrhythmias. A clinical contribution].
Topics: Amiodarone; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Digitalis Glycosides; Electric Stimulation; Female; Heart Block; Humans; Male; Middle Aged; Quinidine; Tachycardia | 1982 |
[Comparison of the effectiveness of amiodarone and quinidine in the prevention of arrhythmia].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiomyopathies; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Quinidine | 1980 |
Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Time Factors | 1981 |
[Digoxin-quinidine and digoxin-amiodarone interactions. Effects on blood levels of the cardioactive glycoside].
Topics: Adult; Aged; Amiodarone; Benzofurans; Coronary Disease; Digoxin; Drug Interactions; Female; Heart Diseases; Humans; Hypertension; Male; Middle Aged; Quinidine; Rheumatic Heart Disease | 1981 |
Antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Humans; Lidocaine; Quinidine; Verapamil | 1981 |
[Pharmacological therapy and prevention of recurrent ventricular tachycardia].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Bunaftine; Disopyramide; Humans; Male; Middle Aged; Procainamide; Propranolol; Quinidine; Tachycardia | 1981 |
[Conversion of recent atrial fibrillation to sinus rhythm. Predictive value of the clinical and echocardiographic parameters].
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Digitalis Glycosides; Echocardiography; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Quinidine; Verapamil | 1981 |
Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway.
Topics: Accessory Nerve; Adolescent; Adult; Ajmaline; Amiodarone; Child; Female; Heart Block; Humans; Male; Middle Aged; Neural Conduction; Procainamide; Quinidine; Refractory Period, Electrophysiological; Time Factors; Wolff-Parkinson-White Syndrome | 1980 |
Digoxin-quinidine and digoxin-amiodarone interactions: frequency of occurrence and monitoring in Australian repatriation hospitals.
Topics: Absorption; Amiodarone; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Monitoring, Physiologic; Pharmacy Service, Hospital; Quinidine | 1995 |
Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Drug Resistance; Humans; Leukemia; Membrane Glycoproteins; Propranolol; Propylamines; Quinidine; Quinine; Rhodamine 123; Rhodamines; Stereoisomerism; Tumor Cells, Cultured | 1994 |
Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Drug Combinations; Female; Humans; Male; Middle Aged; Quinidine; Sotalol; Tachycardia; Torsades de Pointes; Ventricular Fibrillation | 1994 |
Antiarrhythmic drugs in the management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Flecainide; Heart; Humans; Propafenone; Quinidine | 1993 |
Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
Topics: Adult; Aged; Amiodarone; Coronary Disease; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Quinidine; Tachycardia, Ventricular | 1993 |
Abnormal QT intervals associated with negative T waves induced by antiarrhythmic drugs are rapidly reduced using magnesium sulfate as an antidote.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Electrocardiography; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Quinidine; Sarcoplasmic Reticulum | 1993 |
The effectiveness and safety of the simultaneous administration of quinidine and amiodarone in the conversion of chronic atrial fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Chronic Disease; Drug Combinations; Electrocardiography; Female; Forecasting; Heart Rate; Humans; Male; Middle Aged; Quinidine | 1993 |
[Torsade de pointes during quinidine and amiodarone therapy].
Topics: Amiodarone; Catheter Ablation; Female; Humans; Middle Aged; Pacemaker, Artificial; Quinidine; Torsades de Pointes | 1996 |
[Influence of anti-arrhythmia agents on heart rate variability].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Heart Diseases; Heart Rate; Humans; Middle Aged; Quinidine; Tachycardia, Ventricular | 1997 |
Amiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Quinidine; Tachycardia, Ventricular; Torsades de Pointes | 1997 |
Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Heart Failure; Humans; Interleukin-1; Interleukin-6; Lidocaine; Monocytes; Osmolar Concentration; Quinidine; Tumor Necrosis Factor-alpha | 1997 |
Differential effects of D-sotalol, quinidine, and amiodarone on dispersion of ventricular repolarization in the isolated rabbit heart.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Heart Ventricles; In Vitro Techniques; Quinidine; Rabbits; Sotalol; Ventricular Function | 1997 |
Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Quinidine | 1998 |
[Paroxysmal atrial fibrillation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electric Countershock; Female; Humans; Middle Aged; Monitoring, Physiologic; Pacemaker, Artificial; Prognosis; Quinidine; Recurrence; Risk Factors; Sotalol; Thromboembolism; Vasodilator Agents | 2000 |
Amiodarone-induced AV block and ventricular standstill. A forme fruste of an idiopathic long QT syndrome.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Female; Heart Block; Humans; Long QT Syndrome; Quinidine; Time Factors; Vasodilator Agents | 2000 |
Metabolism of amiodarone (Part III): identification of rabbit cytochrome P450 isoforms involved in the hydroxylation of mono-N-desethylamiodarone.
Topics: Amiodarone; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Aryl Hydrocarbon Hydroxylases; Benzoflavones; Chromatography, High Pressure Liquid; Cimetidine; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ketoconazole; Kinetics; Microsomes, Liver; Midazolam; Models, Chemical; Oxidoreductases, N-Demethylating; Protein Isoforms; Quinidine; Rabbits; Rifampin; Time Factors | 2001 |
Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Heart Rate; Infusions, Intravenous; Male; Phenylephrine; Propanolamines; Quinidine; Rabbits; Sotalol; Torsades de Pointes | 2002 |
MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs.
Topics: Amiodarone; Angina Pectoris; Animals; Anti-Arrhythmia Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Digoxin; Drug Interactions; Humans; LLC-PK1 Cells; Quinidine; Swine | 2002 |
Amiodarone attenuates fluoride-induced hyperkalemia in vitro.
Topics: Amiodarone; Humans; Hyperkalemia; In Vitro Techniques; Potassium; Potassium Channel Blockers; Quinidine; Sodium Fluoride | 2003 |
Atrial fibrillation: rate control often better than rhythm control.
Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramide; Electric Countershock; Flecainide; Heart Rate; Humans; Netherlands; Platelet Aggregation Inhibitors; Propafenone; Quinidine; Sotalol; United States | 2004 |
[Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiology Service, Hospital; Electric Countershock; Female; Follow-Up Studies; Hospital Departments; Humans; Hungary; Male; Middle Aged; Prajmaline; Propafenone; Quinidine; Retrospective Studies; Sotalol | 2004 |
Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Contraindications; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Quinidine; Registries; Sotalol | 2004 |
The influence of extracellular acidosis on the effect of IKr blockers.
Topics: Acidosis; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Humans; Hydantoins; Imidazolidines; Myocardial Infarction; Oocytes; Phenethylamines; Piperazines; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Sulfonamides; Trans-Activators; Xenopus laevis | 2005 |
A 25-year control of idiopathic ventricular fibrillation with electrophysiologic-guided antiarrhythmic drug therapy.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Follow-Up Studies; Humans; Male; Quinidine; Time Factors; Treatment Outcome; Ventricular Fibrillation | 2004 |
Use of a failing rabbit heart as a model to predict torsadogenicity.
Topics: Amiodarone; Animals; Cardiac Output, Low; Cisapride; Dose-Response Relationship, Drug; Electrocardiography; Models, Animal; Phenethylamines; Quaternary Ammonium Compounds; Quinidine; Rabbits; Sulfonamides; Torsades de Pointes; Verapamil | 2006 |
[Long QT syndrome induced by cordaron and quinidine].
Topics: Amiodarone; Anemia, Hemolytic; Anti-Arrhythmia Agents; Female; Humans; Hypertension; Long QT Syndrome; Middle Aged; Myocardial Ischemia; Quinidine; Torsades de Pointes; Ventricular Fibrillation | 2007 |
Successful conversion of recent-onset atrial fibrillation by sequential administration of up to three antiarrhythmic drugs.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Administration Schedule; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Quinidine; Treatment Outcome; Young Adult | 2008 |
Inhibition of ATP-sensitive K+ channels and L-type Ca2+ channels by amiodarone elicits contradictory effect on insulin secretion in MIN6 cells.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; KATP Channels; Membrane Potentials; Mice; Nifedipine; Osmolar Concentration; Patch-Clamp Techniques; Potassium Channel Blockers; Quinidine | 2011 |
Physiologically based pharmacokinetic modelling and in vivo [I]/K(i) accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate.
Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; beta-Alanine; Clarithromycin; Dabigatran; Digoxin; Dronedarone; Drug Interactions; Humans; Models, Biological; Pyridines; Quinidine; Verapamil | 2014 |
Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Drug Evaluation; Drug Resistance; Drug Substitution; Electrocardiography; Female; Follow-Up Studies; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Postoperative Complications; Quinidine; Recurrence; Retrospective Studies; Tachycardia, Ventricular; Thrombocytopenia; Ventricular Fibrillation; Ventricular Premature Complexes | 2019 |
Drug-Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats.
Topics: Amiodarone; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Male; Molecular Structure; Pyrrolidines; Quinidine; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tandem Mass Spectrometry | 2019 |
Quinidine hypersensitivity: a side effect of a forgotten antiarrhythmic.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Female; Humans; Quinidine; Tachycardia, Ventricular | 2020 |